APO Research
Talk to an analyst

APO RESEARCH · REPORT

Recombinant Uricase

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Recombinant Uricase Industry Growth and Trends Forecast to 2032

27 December 202578 pages

Choose your research edition.

Industry ResearchRecombinant Uricase Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Recombinant Uricase Industry Growth and Trends Forecast to 203278 pages · $3,450 USDMarket StructureGlobal Recombinant Uricase Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032172 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Recombinant Uricase Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Recombinant Uricase Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Recombinant Uricase market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Recombinant Uricase is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Recombinant Uricase is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Recombinant Uricase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Recombinant Uricase include Horizo​​n Therapeutics and Sanofi among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Recombinant Uricase market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Recombinant Uricase market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Recombinant Uricase market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Recombinant Uricase.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Recombinant Uricase market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Recombinant Uricase Market by Company

Horizo​​n Therapeutics

Sanofi

Recombinant Uricase Segment by Type

Rasburicase

Pegloticase

Other

Recombinant Uricase Segment by Application

Gout

Kidney Stones

Cancer

Other

Recombinant Uricase Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Recombinant Uricase market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Recombinant Uricase and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Recombinant Uricase.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Recombinant Uricase manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Recombinant Uricase in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Rasburicase Table 2. Major Company of Pegloticase Table 3. Major Company of Other Table 4. Global Recombinant Uricase Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Recombinant Uricase Sales by Type (2021-2026) & (K Units) Table 6. Global Recombinant Uricase Sales Market Share in Volume by Type (2021-2026) Table 7. Global Recombinant Uricase Sales by Type (2021-2026) & (US$ Million) Table 8. Global Recombinant Uricase Sales Market Share in Value by Type (2021-2026) Table 9. Global Recombinant Uricase Price by Type (2021-2026) & (US$/Unit) Table 10. Global Recombinant Uricase Sales by Type (2027-2032) & (K Units) Table 11. Global Recombinant Uricase Sales Market Share in Volume by Type (2027-2032) Table 12. Global Recombinant Uricase Sales by Type (2027-2032) & (US$ Million) Table 13. Global Recombinant Uricase Sales Market Share in Value by Type (2027-2032) Table 14. Global Recombinant Uricase Price by Type (2027-2032) & (US$/Unit) Table 15. North America Recombinant Uricase Sales by Type (2021-2026) & (K Units) Table 16. North America Recombinant Uricase Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Recombinant Uricase Sales by Type (2021-2026) & (K Units) Table 18. Europe Recombinant Uricase Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Recombinant Uricase Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Recombinant Uricase Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Recombinant Uricase Sales by Type (2021-2026) & (K Units) Table 22. Latin America Recombinant Uricase Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Recombinant Uricase Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Recombinant Uricase Sales by Type (2021-2026) & (US$ Million) Table 25. Recombinant Uricase Industry Trends Table 26. Recombinant Uricase Industry Drivers Table 27. Recombinant Uricase Industry Opportunities and Challenges Table 28. Recombinant Uricase Industry Restraints Table 29. Global Recombinant Uricase Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Recombinant Uricase Revenue Market Share by Company (2021-2026) Table 31. Global Recombinant Uricase Sales by Company (2021-2026) & (K Units) Table 32. Global Recombinant Uricase Sales Share by Company (2021-2026) Table 33. Global Recombinant Uricase Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Recombinant Uricase Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Recombinant Uricase Major Company Production Sites and Headquarters Table 36. Global Recombinant Uricase Company, Product Type & Application Table 37. Global Recombinant Uricase Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Recombinant Uricase by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Recombinant Uricase Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Recombinant Uricase Sales by Region (2021-2026) & (K Units) Table 42. Global Recombinant Uricase Sales Market Share in Volume by Region (2021-2026) Table 43. Global Recombinant Uricase Sales by Region (2021-2026) & (US$ Million) Table 44. Global Recombinant Uricase Sales Market Share in Value by Region (2021-2026) Table 45. Global Recombinant Uricase Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Recombinant Uricase Sales by Region (2027-2032) & (K Units) Table 47. Global Recombinant Uricase Sales Market Share in Volume by Region (2027-2032) Table 48. Global Recombinant Uricase Sales by Region (2027-2032) & (US$ Million) Table 49. Global Recombinant Uricase Sales Market Share in Value by Region (2027-2032) Table 50. Global Recombinant Uricase Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Recombinant Uricase Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Recombinant Uricase Sales by Application (2021-2026) & (K Units) Table 53. Global Recombinant Uricase Sales Market Share in Volume by Application (2021-2026) Table 54. Global Recombinant Uricase Sales by Application (2021-2026) & (US$ Million) Table 55. Global Recombinant Uricase Sales Market Share in Value by Application (2021-2026) Table 56. Global Recombinant Uricase Price by Application (2021-2026) & (US$/Unit) Table 57. Global Recombinant Uricase Sales by Application (2027-2032) & (K Units) Table 58. Global Recombinant Uricase Sales Market Share in Volume by Application (2027-2032) Table 59. Global Recombinant Uricase Sales by Application (2027-2032) & (US$ Million) Table 60. Global Recombinant Uricase Sales Market Share in Value by Application (2027-2032) Table 61. Global Recombinant Uricase Price by Application (2027-2032) & (US$/Unit) Table 62. North America Recombinant Uricase Sales by Application (2021-2026) & (K Units) Table 63. North America Recombinant Uricase Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Recombinant Uricase Sales by Application (2021-2026) & (K Units) Table 65. Europe Recombinant Uricase Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Recombinant Uricase Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Recombinant Uricase Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Recombinant Uricase Sales by Application (2021-2026) & (K Units) Table 69. Latin America Recombinant Uricase Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Recombinant Uricase Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Recombinant Uricase Sales by Application (2021-2026) & (US$ Million) Table 72. Horizo​​n Therapeutics Company Information Table 73. Horizo​​n Therapeutics Business Overview Table 74. Horizo​​n Therapeutics Recombinant Uricase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Horizo​​n Therapeutics Recombinant Uricase Product Portfolio Table 76. Horizo​​n Therapeutics Recent Development Table 77. Sanofi Company Information Table 78. Sanofi Business Overview Table 79. Sanofi Recombinant Uricase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Sanofi Recombinant Uricase Product Portfolio Table 81. Sanofi Recent Development Table 82. North America Recombinant Uricase Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 83. North America Recombinant Uricase Sales by Country (2021-2026) & (K Units) Table 84. North America Recombinant Uricase Sales Market Share by Country (2021-2026) Table 85. North America Recombinant Uricase Sales Forecast by Country (2027-2032) & (K Units) Table 86. North America Recombinant Uricase Sales Market Share Forecast by Country (2027-2032) Table 87. North America Recombinant Uricase Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 88. North America Recombinant Uricase Market Size by Country (2021-2026) & (US$ Million) Table 89. North America Recombinant Uricase Market Share by Country (2021-2026) Table 90. North America Recombinant Uricase Market Size Forecast by Country (2027-2032) & (US$ Million) Table 91. North America Recombinant Uricase Market Share Forecast by Country (2027-2032) Table 92. Europe Recombinant Uricase Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 93. Europe Recombinant Uricase Sales by Country (2021-2026) & (K Units) Table 94. Europe Recombinant Uricase Sales Market Share by Country (2021-2026) Table 95. Europe Recombinant Uricase Sales Forecast by Country (2027-2032) & (K Units) Table 96. Europe Recombinant Uricase Sales Market Share Forecast by Country (2027-2032) Table 97. Europe Recombinant Uricase Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 98. Europe Recombinant Uricase Market Size by Country (2021-2026) & (US$ Million) Table 99. Europe Recombinant Uricase Market Share by Country (2021-2026) Table 100. Europe Recombinant Uricase Market Size Forecast by Country (2027-2032) & (US$ Million) Table 101. Europe Recombinant Uricase Market Share Forecast by Country (2027-2032) Table 102. Asia-Pacific Recombinant Uricase Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 103. Asia-Pacific Recombinant Uricase Sales by Country (2021-2026) & (K Units) Table 104. Asia-Pacific Recombinant Uricase Sales Market Share by Country (2021-2026) Table 105. Asia-Pacific Recombinant Uricase Sales Forecast by Country (2027-2032) & (K Units) Table 106. Asia-Pacific Recombinant Uricase Sales Market Share Forecast by Country (2027-2032) Table 107. Asia-Pacific Recombinant Uricase Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 108. Asia-Pacific Recombinant Uricase Market Size by Country (2021-2026) & (US$ Million) Table 109. Asia-Pacific Recombinant Uricase Market Share by Country (2021-2026) Table 110. Asia-Pacific Recombinant Uricase Market Size Forecast by Country (2027-2032) & (US$ Million) Table 111. Asia-Pacific Recombinant Uricase Market Share Forecast by Country (2027-2032) Table 112. Latin America Recombinant Uricase Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 113. Latin America Recombinant Uricase Sales by Country (2021-2026) & (K Units) Table 114. Latin America Recombinant Uricase Sales Market Share by Country (2021-2026) Table 115. Latin America Recombinant Uricase Sales Forecast by Country (2027-2032) & (K Units) Table 116. Latin America Recombinant Uricase Sales Market Share Forecast by Country (2027-2032) Table 117. Latin America Recombinant Uricase Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. Latin America Recombinant Uricase Market Size by Country (2021-2026) & (US$ Million) Table 119. Latin America Recombinant Uricase Market Share by Country (2021-2026) Table 120. Latin America Recombinant Uricase Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. Latin America Recombinant Uricase Market Share Forecast by Country (2027-2032) Table 122. Middle East and Africa Recombinant Uricase Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 123. Middle East and Africa Recombinant Uricase Sales by Country (2021-2026) & (K Units) Table 124. Middle East and Africa Recombinant Uricase Sales Market Share by Country (2021-2026) Table 125. Middle East and Africa Recombinant Uricase Sales Forecast by Country (2027-2032) & (K Units) Table 126. Middle East and Africa Recombinant Uricase Sales Market Share Forecast by Country (2027-2032) Table 127. Middle East and Africa Recombinant Uricase Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Middle East and Africa Recombinant Uricase Market Size by Country (2021-2026) & (US$ Million) Table 129. Middle East and Africa Recombinant Uricase Market Share by Country (2021-2026) Table 130. Middle East and Africa Recombinant Uricase Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Middle East and Africa Recombinant Uricase Market Share Forecast by Country (2027-2032) Table 132. Key Raw Materials Table 133. Raw Materials Key Suppliers Table 134. Recombinant Uricase Distributors List Table 135. Recombinant Uricase Customers List Table 136. Research Programs/Design for This Report Table 137. Authors List of This Report Table 138. Secondary Sources Table 139. Primary Sources List of Figures Figure 1. Recombinant Uricase Image Figure 2. Global Recombinant Uricase Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Recombinant Uricase Market Size (2021-2032) & (US$ Million) Figure 4. Global Recombinant Uricase Sales (2021-2032) & (K Units) Figure 5. Rasburicase Image Figure 6. Global Rasburicase Sales YoY Growth (2021-2032) & (K Units) Figure 7. Pegloticase Image Figure 8. Global Pegloticase Sales YoY Growth (2021-2032) & (K Units) Figure 9. Other Image Figure 10. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Recombinant Uricase Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Recombinant Uricase Market Share by Type 2025 VS 2032 Figure 13. North America Recombinant Uricase Sales Market Share in Volume by Type in 2025 Figure 14. North America Recombinant Uricase Sales Market Share in Value by Type in 2025 Figure 15. Europe Recombinant Uricase Sales Market Share in Volume by Type in 2025 Figure 16. Europe Recombinant Uricase Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Recombinant Uricase Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Recombinant Uricase Sales Market Share in Value by Type in 2025 Figure 19. Latin America Recombinant Uricase Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Recombinant Uricase Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Recombinant Uricase Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Recombinant Uricase Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Recombinant Uricase Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Gout Image Figure 26. Global Gout Sales YoY Growth (2021-2032) & (K Units) Figure 27. Kidney Stones Image Figure 28. Global Kidney Stones Sales YoY Growth (2021-2032) & (K Units) Figure 29. Cancer Image Figure 30. Global Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 31. Other Image Figure 32. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Recombinant Uricase Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Recombinant Uricase Market Share by Application 2025 VS 2032 Figure 35. North America Recombinant Uricase Sales Market Share in Volume by Application in 2025 Figure 36. North America Recombinant Uricase Sales Market Share in Value by Application in 2025 Figure 37. Europe Recombinant Uricase Sales Market Share in Volume by Application in 2025 Figure 38. Europe Recombinant Uricase Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Recombinant Uricase Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Recombinant Uricase Sales Market Share in Value by Application in 2025 Figure 41. Latin America Recombinant Uricase Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Recombinant Uricase Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Recombinant Uricase Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Recombinant Uricase Sales Market Share in Value by Application in 2025 Figure 45. North America Recombinant Uricase Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Recombinant Uricase Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Recombinant Uricase Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Recombinant Uricase Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Recombinant Uricase Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Recombinant Uricase Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Recombinant Uricase Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Recombinant Uricase Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Recombinant Uricase Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Recombinant Uricase Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Recombinant Uricase Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Recombinant Uricase Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Recombinant Uricase Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Recombinant Uricase Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Recombinant Uricase Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Recombinant Uricase Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Recombinant Uricase Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Recombinant Uricase Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Recombinant Uricase Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Recombinant Uricase Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Recombinant Uricase Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Recombinant Uricase Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Rasburicase
  • Pegloticase
  • Other
Applications
  • Gout
  • Kidney Stones
  • Cancer
  • Other
Companies covered
  • Horizo​​n Therapeutics
  • Sanofi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Recombinant Uricase Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Recombinant Uricase Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Recombinant Uricase Market by Type
  6. 1.3.1 Rasburicase
  7. 1.3.2 Pegloticase
  8. 1.3.3 Other
  9. 1.4 Global Recombinant Uricase Market Size by Type
  10. 1.4.1 Global Recombinant Uricase Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Recombinant Uricase Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Recombinant Uricase Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Recombinant Uricase Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Recombinant Uricase Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Recombinant Uricase Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Recombinant Uricase Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Recombinant Uricase Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Recombinant Uricase Industry Trends
  2. 2.2 Recombinant Uricase Industry Drivers
  3. 2.3 Recombinant Uricase Industry Opportunities and Challenges
  4. 2.4 Recombinant Uricase Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Recombinant Uricase Revenue (2021-2026)
  2. 3.2 Global Top Players by Recombinant Uricase Sales (2021-2026)
  3. 3.3 Global Top Players by Recombinant Uricase Price (2021-2026)
  4. 3.4 Global Recombinant Uricase Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Recombinant Uricase Major Company Production Sites & Headquarters
  6. 3.6 Global Recombinant Uricase Company, Product Type & Application
  7. 3.7 Global Recombinant Uricase Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Recombinant Uricase Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Recombinant Uricase Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Recombinant Uricase Tier 1, Tier 2, and Tier 3
4 Recombinant Uricase Regional Status and Outlook
  1. 4.1 Global Recombinant Uricase Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Recombinant Uricase Historic Market Size by Region
  3. 4.2.1 Global Recombinant Uricase Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Recombinant Uricase Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Recombinant Uricase Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Recombinant Uricase Forecasted Market Size by Region
  7. 4.3.1 Global Recombinant Uricase Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Recombinant Uricase Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Recombinant Uricase Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Recombinant Uricase by Application
  1. 5.1 Recombinant Uricase Market by Application
  2. 5.1.1 Gout
  3. 5.1.2 Kidney Stones
  4. 5.1.3 Cancer
  5. 5.1.4 Other
  6. 5.2 Global Recombinant Uricase Market Size by Application
  7. 5.2.1 Global Recombinant Uricase Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Recombinant Uricase Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Recombinant Uricase Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Recombinant Uricase Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Recombinant Uricase Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Recombinant Uricase Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Recombinant Uricase Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Recombinant Uricase Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Horizo​​n Therapeutics
  2. 6.1.1 Horizo​​n Therapeutics Company Information
  3. 6.1.2 Horizo​​n Therapeutics Business Overview
  4. 6.1.3 Horizo​​n Therapeutics Recombinant Uricase Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Horizo​​n Therapeutics Recombinant Uricase Product Portfolio
  6. 6.1.5 Horizo​​n Therapeutics Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi Recombinant Uricase Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi Recombinant Uricase Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
7 North America by Country
  1. 7.1 North America Recombinant Uricase Sales by Country
  2. 7.1.1 North America Recombinant Uricase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Recombinant Uricase Sales by Country (2021-2026)
  4. 7.1.3 North America Recombinant Uricase Sales Forecast by Country (2027-2032)
  5. 7.2 North America Recombinant Uricase Market Size by Country
  6. 7.2.1 North America Recombinant Uricase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Recombinant Uricase Market Size by Country (2021-2026)
  8. 7.2.3 North America Recombinant Uricase Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Recombinant Uricase Sales by Country
  2. 8.1.1 Europe Recombinant Uricase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Recombinant Uricase Sales by Country (2021-2026)
  4. 8.1.3 Europe Recombinant Uricase Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Recombinant Uricase Market Size by Country
  6. 8.2.1 Europe Recombinant Uricase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Recombinant Uricase Market Size by Country (2021-2026)
  8. 8.2.3 Europe Recombinant Uricase Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Recombinant Uricase Sales by Country
  2. 9.1.1 Asia-Pacific Recombinant Uricase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Recombinant Uricase Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Recombinant Uricase Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Recombinant Uricase Market Size by Country
  6. 9.2.1 Asia-Pacific Recombinant Uricase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Recombinant Uricase Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Recombinant Uricase Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Recombinant Uricase Sales by Country
  2. 10.1.1 South America Recombinant Uricase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Recombinant Uricase Sales by Country (2021-2026)
  4. 10.1.3 South America Recombinant Uricase Sales Forecast by Country (2027-2032)
  5. 10.2 South America Recombinant Uricase Market Size by Country
  6. 10.2.1 South America Recombinant Uricase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Recombinant Uricase Market Size by Country (2021-2026)
  8. 10.2.3 South America Recombinant Uricase Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Recombinant Uricase Sales by Country
  2. 11.1.1 Middle East and Africa Recombinant Uricase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Recombinant Uricase Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Recombinant Uricase Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Recombinant Uricase Market Size by Country
  6. 11.2.1 Middle East and Africa Recombinant Uricase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Recombinant Uricase Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Recombinant Uricase Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Recombinant Uricase Value Chain Analysis
  2. 12.1.1 Recombinant Uricase Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Recombinant Uricase Production Mode & Process
  7. 12.2 Recombinant Uricase Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Recombinant Uricase Distributors
  10. 12.2.3 Recombinant Uricase Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst